Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the ...

Landmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide ...

While GLP-1 agonists have grabbed investor attention for their potential as weight loss aids, these medicines also form a ...

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...

Equity-Insider.com News Commentary – Here's the quiet shift in medtech right now: the global medical imaging market is on track to grow from $41.64 billion in 2024 to $67.87 billion by 2034 [1], and ...

The Middle East and Africa Continuous Glucose Monitoring (CGM) market is set for growth, driven by increasing diabetes rates, technological advancements, and healthcare awareness. Projected to rise ...

MiniMed (Nasdaq:MMED) announced today that it received approval in Canada for new software for its MiniMed 780G system.

MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new ...

Monitoring a constant stream of data doesn’t help people make health-related decisions and can lead to confusion and needless ...

So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...